Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
122.8 USD | +1.45% | -1.56% | -2.44% |
16/05 | Morgan Stanley Adjusts Ascendis Pharma Price Target to $140 From $116, Maintains Equal Weight Rating | MT |
14/05 | US Equity Markets Close Higher Tuesday as Producer Prices Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.44% | 6.94B | |
+9.71% | 115B | |
+13.19% | 107B | |
-13.28% | 22.31B | |
-3.44% | 21.6B | |
-5.29% | 18.23B | |
-38.57% | 17.62B | |
+8.09% | 14.26B | |
+34.46% | 12.37B | |
-26.74% | 8.28B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Ascendis Pharma Signs Exclusive License Deal With Japan's Teijin